https://scholars.lib.ntu.edu.tw/handle/123456789/426641
Title: | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Authors: | Wang, CK MING-CHIH HO Su C.-W. Wang T.-E. Dai C.-Y. CHIEN-HUNG CHEN Chen R.-C. Yang S.-S. Hung C.-F. Huang S.-F. Liao L.-Y. Huo T.-I. Wu C.-C. PO-HUANG LEE Ting C.-T. Lee W.-C. Chau G.-Y. Wang C.-C. Lee K.-T. Huang Y.-H. Lin S.-M. GUAN-TARN HUANG Chen K.-Y. Lin X.-Z. Hwang J.-I. Chiou Y.-Y. Wang C.-K. Hu J.-T. Chen S.-C. PO-CHIN LIANG Lee R.-C. Wu D.-K. Lin C.-Y. Lin C.-C. ANN-LII CHENG CHIUN HSU Chao Y. Chen L.-T. Wang P.-M. Wang P.-M. Hong J.-H. Hsu H.-C. Chen S.-W. Leung S.W. CHIA-HSIEN CHENG Wu J.-C. Wu C.-Y. Hsu Y.-C. Hsu C.-W. YEN-HSUAN NI Lin C.-L. Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group Surveillance group Diagnosis group Staging group Surgery group TACE/TARE/HAI group Target therapy/systemic therapy group Radiotherapy group Prevention group Drafting group |
Keywords: | Diagnosis; Hepatocellular carcinoma; Staging; Surveillance; Treatment | Issue Date: | May-2018 | Publisher: | ELSEVIER TAIWAN | Journal Volume: | 117 | Journal Issue: | 5 | Start page/Pages: | 381 | Source: | Journal of the Formosan Medical Association = Taiwan yi zhi | Abstract: | Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan produced the management consensus guideline for HCC. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/426641 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2017.09.007 | SDG/Keyword: | alpha fetoprotein; antivirus agent; cancer vaccine; cytotoxic agent; gadoxetic acid; illicit drug; interferon; new drug; nonnucleoside reverse transcriptase inhibitor; RNA directed DNA polymerase inhibitor; sorafenib; tumor marker; yttrium 90; advanced cancer; antiviral therapy; Article; ascites; cancer chemotherapy; cancer control; cancer diagnosis; cancer epidemiology; cancer immunization; cancer incidence; cancer patient; cancer prevention; cancer prognosis; cancer radiotherapy; cancer recurrence; cancer staging; cancer surgery; chemoembolization; Child Pugh score; chronic hepatitis B; chronic hepatitis C; computer assisted tomography; consensus; echography; evidence based practice; external beam radiotherapy; Hepatitis B virus; Hepatitis C virus; high risk patient; histopathology; human; liver biopsy; liver cell carcinoma; liver cirrhosis; liver function; medical society; meta analysis (topic); microwave thermotherapy; multicenter study (topic); multidetector computed tomography; national health insurance; nuclear magnetic resonance imaging; pleura effusion; portal vein thrombosis; practice guideline; radioembolization; radiofrequency ablation; randomized controlled trial (topic); risk reduction; systemic therapy; Taiwan; tertiary prevention; tumor ablation; tumor biopsy; tumor vascularization; tumor volume; virus replication; virus transmission; complication; consensus; gastroenterology; hepatitis B; hepatitis C; liver cell carcinoma; liver tumor; Carcinoma, Hepatocellular; Consensus; Gastroenterology; Hepatitis B; Hepatitis C; Humans; Liver Neoplasms; Practice Guidelines as Topic; Societies, Medical; Taiwan |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.